albaconazole

Known as: 7-Chloro-3-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]quinazolin-4-one, 7-chloro-3-(2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl)quinazolin-4(3H)-one 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Synthesis of a strict structural analogue of albaconazole in which the quinazolinone ring is fused by a thiazole moiety led to… (More)
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2013
2013
BACKGROUND Albaconazole is a novel triazole being developed for the oral treatment of fungal diseases. Once-weekly oral dosing… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2009
2009
The efficacy of albaconazole (ABC) was evaluated using a murine model of vaginal Candida albicans infection. Both ABC and… (More)
  • table 1
Is this relevant?
2007
2007
Vulvovaginal candidiasis is a condition that affects a great number of fertile women. It is considered the second cause of… (More)
Is this relevant?
Review
2006
Review
2006
New triazole antifungals (voriconazole, posaconazole, ravuconazole and albaconazole) have been developed to meet the increasing… (More)
Is this relevant?
2005
2005
Minimal inhibitory concentrations (MIC) and minimal fungicidal activity of albaconazole, voriconazole and fluconazole against 55… (More)
Is this relevant?
2004
2004
The activity of albaconazole (UR-9825; J. Uriach & Cía. S.A., Barcelona, Spain) was compared to that of fluconazole against 12… (More)
Is this relevant?
2004
2004
We have determined the in vitro susceptibilities of 57 strains of Cryptococcus gattii to nine antifungal agents and have compared… (More)
  • table 1
  • table 1
  • table 1
  • table 3
  • table 3
Is this relevant?
2004
2004
Albaconazole is an experimental triazole derivative with potent and broad-spectrum antifungal activity and a remarkably long half… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2003
2003
There are no effective therapeutics for treating invasive Scedosporium prolificans infections. Doses of 15, 25, and 50 mg/kg of… (More)
Is this relevant?